The Possible Role of Quinolones in Yersiniosis
The in vitro susceptibility of 135 strains of Yersinia enterocolitica was tested by agar dilution. About 85% of the strains were susceptible to trimethoprim (1 mg/L), tetracycline (4 mg/L), chloramphenicol (4 mg/L) and cefuroxime (8 mg/L); 90 to 100% to piperacillin (16 mg/L), cefotaxime (8 mg/L) and gentamicin (1 mg/L); 100% to ciprofloxacin (≤ 0.016 mg/L), ofloxacin (0.06 mg/L) and pefloxacin (0.12 mg/L).
The outcome of 88 patients, treated for various forms of yersiniosis, showed 15% failure for trimethoprim or co-trimoxazole and tetracycline and 70% failure for cephalosporins and aminoglycoside-β-lactam combinations.
Four patients were successfully treated with ciprofloxacin 500mg orally or 300mg intravenously administered twice daily for up to 6 weeks.
KeywordsOfloxacin Quinolones Trimethoprim Cefuroxime Piperacillin
Unable to display preview. Download preview PDF.
- Bergogne-Berezin E. Penetration of ciprofloxacin into tissue: a review. In Neu & Weuta (Eds) Proceedings First International Ciprofloxacin Workshop, pp. 183–188, Excerpta Medica, Amsterdam, 1986Google Scholar
- Deleers L, Roekaerts F. Effectiveness of ofloxacin in the treatment of wound infections. Fourteenth International Congress of Chemotherapy, Kyoto, June 23–28. Abstract no. S-31-12, 1985Google Scholar
- Dutch Group Standardisation Susceptibility Testing. In Mouton, Van Klingeren (Eds) Standaardisatie van Gevoeligheidsbepalingen. RIVM, Bilthoven, The Netherlands, 1981Google Scholar
- Heesemann J, Eggers Ch, Schröder J, Laufs R. Serological diagnosis of yersiniosis by the immunoblottechnique using plasmid-encoded antigens of Yersinia enterocolitica. In Simon & Wilkinson (Eds) Diagnosis of infectious diseases — new aspects, pp. 79–88, Schattauer, Stuttgart-New York, 1986Google Scholar
- Hoogkamp-Korstanje JAA. Yersiniosis in childhood: incidence and diagnosis. In Simon & Wilkinson (Eds) Diagnosis of infectious diseases — New aspects, pp. 69–77, Schattauer, Stuttgart-New York, in press Hoogkamp-Korstanje JAA, Klein S. Ciprofloxacin in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 18: 407–413, 1986PubMedCrossRefGoogle Scholar
- Schönwald S, Breitenfeld V, Car V, Gmajnicki B. Treatment of acute diarrhoeal syndrome with ciprofloxacin. In Neu & Weuta (Eds) First International Ciprofloxacin Workshop, pp. 353–356, Excerpta Medica, Amsterdam, 1986Google Scholar
- WHO Report. Yersiniosis. Euroreports and studies 60. Copenhagen, 1983Google Scholar